Tryg (CPSE:TRYG) has drawn investor attention after updating its 2026 and 2027 revenue guidance, reporting lower second quarter earnings, and affirming a DKK 2.15 ordinary dividend for the period.
See our latest analysis for Tryg.
At a share price of DKK155.4, Tryg has seen a 3.39% 1 month share price return but is down 5.88% year to date, while its 1 year total shareholder return is 2.72% and 3 year total shareholder return is 34.31%. This suggests that shorter term momentum has faded even as longer term holders have still seen gains.
If recent guidance changes have you reassessing opportunities, it could be a good moment to broaden your search and check out 106 top founder-led companies
After providing softer guidance for 2026, reporting weaker earnings and confirming its dividend, Tryg now trades at DKK 155.4 with mixed signals on quality and growth. Do the current valuation and risks still tilt in favour of buyers?
Most Popular Narrative: 8.4% Undervalued
Based on the most followed narrative, Tryg's fair value is DKK169.67 compared with the last close at DKK155.4, which frames the stock as modestly undervalued in that framework.
The company is focusing on strategic pillars such as Scale & Simplicity, Technical Excellence, and Customer & Commercial Excellence to achieve an insurance service result growth of DKK 1 billion by 2027. This strategy is anticipated to improve revenue and earnings by enhancing operational efficiencies and customer value.
Want to understand why this narrative still points to upside for Tryg even after softer guidance and a court provision hit earnings? The key lies in how revenue, margins and capital returns are expected to evolve together over the next few years and what kind of earnings multiple that cash flow profile could support in 2029.
Result: Fair Value of DKK169.67 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, if inflation keeps claims costs high or if regulators tighten rules on indexation practices, the current Tryg narrative could quickly look too optimistic.
Find out about the key risks to this Tryg narrative.
Next Steps
If the mixed signals around Tryg leave you unsure, consider taking this as your prompt to review the full picture and weigh the company's risks against its potential rewards through 2 key rewards and 1 important warning sign
Looking for more ideas beyond Tryg?
If the Tryg narrative has sharpened your focus, do not stop here. Use the Simply Wall St screener to spot other stocks that could fit your goals.
- Zero in on quality at a discount by scanning for companies flagged in 231 high quality undervalued stocks.
- Strengthen your income stream by reviewing stocks featured in 472 dividend fortresses.
- Dial down risk and potential volatility by checking out opportunities surfaced in 292 resilient stocks with low risk scores.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com